Skip to main content

A Deep Learning Approach for Classifying Nonalcoholic Steatohepatitis Patients from Nonalcoholic Fatty Liver Disease Patients Using Electronic Medical Records

  • Chapter
  • First Online:
Explainable AI in Healthcare and Medicine

Abstract

Nonalcoholic Steatohepatitis (NASH), an advanced stage of Nonalcoholic Fatty Liver Disease (NAFLD) causes liver inflammation and can lead to cirrhosis. In this paper, we present a deep learning approach to identify patients at risk of developing NASH, given that they are suffering from NAFLD. For this, we created two sub cohorts within NASH (NASH suspected (NASH-S) and NASH biopsy-confirmed (NASH-B)) based on the availability of liver biopsy tests. We utilized medical codes from patient electronic medical records and augmented it with patient demographics to build a long short-term memory based NASH vs. NAFLD classifier. The model was trained and tested using five-fold cross-validation and compared with baseline models including XGBoost, random forest and logistic regression. An out-of-sample area under the precision-recall curve (AUPRC) of 0.61 was achieved in classifying NASH patients from NAFLD. When the same model was used to classify out-of-sample NASH-B cohort from NAFLD patients, a highest AUPRC of 0.53 was achieved which was better than other baseline methods.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 199.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Ching, T., Himmelstein, D.S., Beaulieu-Jones, B.K., Kalinin, A.A., Do, B.T., Way, G.P., Ferrero, E., Agapow, P.M., Zietz, M., Hoffman, M.M., et al.: Opportunities and obstacles for deep learning in biology and medicine. J. R. Soc. Interface 15(141), 20170387 (2018)

    Article  Google Scholar 

  2. Choi, E., Bahadori, M.T., Schuetz, A., Stewart, W.F., Sun, J.: Doctor AI: predicting clinical events via recurrent neural networks. In: Machine Learning for Healthcare Conference, pp. 301–318 (2016)

    Google Scholar 

  3. Dyson, J.K., Anstee, Q.M., McPherson, S.: Non-alcoholic fatty liver disease: a practical approach to diagnosis and staging. Frontline Gastroenterol. 5(3), 211–218 (2014)

    Article  Google Scholar 

  4. Farrell, G.C., Larter, C.Z.: Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology 43(S1), S99–S112 (2006)

    Article  Google Scholar 

  5. Hochreiter, S., Schmidhuber, J.: Long short-term memory. Neural Comput. 9(8), 1735–1780 (1997)

    Article  Google Scholar 

  6. Michelotti, G.A., Machado, M.V., Diehl, A.M.: NAFLD, NASH and liver cancer. Nat. Rev. Gastroenterol. Hepatol. 10(11), 656 (2013)

    Article  Google Scholar 

  7. Mikolov, T., Sutskever, I., Chen, K., Corrado, G.S., Dean, J.: Distributed representations of words and phrases and their compositionality. In: Advances in Neural Information Processing Systems, pp. 3111–3119 (2013)

    Google Scholar 

  8. Neuschwander-Tetri, B.A., Brunt, E.M., Wehmeier, K.R., Oliver, D., Bacon, B.R.: Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the ppar-\(\gamma \) ligand rosiglitazone. Hepatology 38(4), 1008–1017 (2003)

    Article  Google Scholar 

  9. Ratziu, V., Goodman, Z., Sanyal, A.: Current efforts and trends in the treatment of NASH. J. Hepatol. 62(1), S65–S75 (2015)

    Article  Google Scholar 

  10. Rotmensch, M., Halpern, Y., Tlimat, A., Horng, S., Sontag, D.: Learning a health knowledge graph from electronic medical records. Sci. Rep. 7(1), 5994 (2017)

    Article  Google Scholar 

  11. Saria, S.: The digital patient: machine learning techniques for analyzing electronic health record data. Ph.D. thesis, Stanford University (2011)

    Google Scholar 

  12. Sumida, Y., Yoneda, M.: Current and future pharmacological therapies for NAFLD/NASH. J. Gastroenterol. 53(3), 362–376 (2018)

    Article  Google Scholar 

  13. Wree, A., Broderick, L., Canbay, A., Hoffman, H.M., Feldstein, A.E.: From NAFLD to NASH to cirrhosis-new insights into disease mechanisms. Nat. Rev. Gastroenterol. Hepatol. 10(11), 627 (2013)

    Article  Google Scholar 

  14. Younossi, Z., Anstee, Q.M., Marietti, M., Hardy, T., Henry, L., Eslam, M., George, J., Bugianesi, E.: Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat. Rev. Gastroenterol. Hepatol. 15(1), 11 (2018)

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Pradyumna Byappanahalli Suresha .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2021 The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Suresha, P.B., Wang, Y., Xiao, C., Glass, L., Yuan, Y., Clifford, G.D. (2021). A Deep Learning Approach for Classifying Nonalcoholic Steatohepatitis Patients from Nonalcoholic Fatty Liver Disease Patients Using Electronic Medical Records. In: Shaban-Nejad, A., Michalowski, M., Buckeridge, D.L. (eds) Explainable AI in Healthcare and Medicine. Studies in Computational Intelligence, vol 914. Springer, Cham. https://doi.org/10.1007/978-3-030-53352-6_10

Download citation

Publish with us

Policies and ethics